TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20491229

Group type: EXPERIMENTAL
Intervention: Diode laser (GaAIAs ‐ 780 nm) applied on the temporalis and masseter muscles, energetic doses of 25 J/cm2 and 60 J/cm2, applied twice a week for four weeks
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 48
Study: 18976996

Group type: EXPERIMENTAL
Intervention: Flywheel training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Weight-lifting training
Number of subjects: 24
Study: 16093742

Group type: EXPERIMENTAL
Intervention: Self-reported sexual abuse
Number of subjects: 649

Group type: EXPERIMENTAL
Intervention: Documented maltreatment
Number of subjects: 649

Group type: EXPERIMENTAL
Intervention: Self-reported physical abuse
Number of subjects: 649
Study: 11978902

Group type: EXPERIMENTAL
Intervention: Risedronate treatment for 3 years
Number of subjects: 1000
Study: 11955465

Group type: EXPERIMENTAL
Intervention: Naloxone 125 microg/kg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 9592638

Group type: EXPERIMENTAL
Intervention: Inpatient management (group A)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Outpatient management (group B)
Number of subjects: 114
Study: 7642415

Group type: EXPERIMENTAL
Intervention: Alternating chemo-radiotherapy (Cisplatin 20 mg/mq and 5-Fluorouracil 200 mg/mq daily for 5 days) with two cycles of 20 Gy/10 fractions/12 days each.
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Alternating chemo-radiotherapy (Cisplatin 20 mg/mq and Methotrexate 40 mg/mq instead of 5-Fluorouracil) with two cycles of 25 Gy/10 fractions/12 days each.
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Alternating chemo-radiotherapy (Cisplatin and 5-Fluorouracil) with varying radiotherapy schedules.
Number of subjects: 76
Study: 2787514

Group type: EXPERIMENTAL
Intervention: Auricular Group (n = 17)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Somatic Group (n = 17)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Combined Group (n = 17)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control Group (n = 16)
Number of subjects: 67
Study: 582983

Group type: EXPERIMENTAL
Intervention: naproxen
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: tolbutamide
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: naproxen + tolbutamide
Number of subjects: 16
Study: 30908611

Group type: EXPERIMENTAL
Intervention: Endovenous laser ablation (EVLA)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Mechanochemical ablation (MOCA)
Number of subjects: 125
Study: 28874146

Group type: EXPERIMENTAL
Intervention: HRV-biofeedback
Number of subjects: 27

Group type: COMPARATOR
Intervention: Rehabilitative treatment alone (control)
Number of subjects: 27
Study: 26124031

Group type: EXPERIMENTAL
Intervention: Intrusive force of 125 g (light)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intrusive force of 250 g (heavy)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No force applied (control group)
Number of subjects: 20
Study: 24080858

Group type: EXPERIMENTAL
Intervention: Red laser treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Green laser treatment
Number of subjects: 30
Study: 21192139

Group type: EXPERIMENTAL
Intervention: Sertraline (up to 200 mg daily)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study: 19581310

Group type: EXPERIMENTAL
Intervention: Concurrent three-dimensional conformal radiotherapy (3D‐CRT) and androgen deprivation (AD)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Short neoadjuvant androgen deprivation (SNAD) (<=3 months)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Long neoadjuvant androgen deprivation (LNAD) (>3 months)
Number of subjects: 52
Study: 17180695

Group type: EXPERIMENTAL
Intervention: Homeopathic remedy
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study: 15541220

Group type: EXPERIMENTAL
Intervention: Chromatographically purified rabies vaccine (CPRV)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Human diploid cell vaccine (HDCV)
Number of subjects: 135
Study: 11975819

Group type: EXPERIMENTAL
Intervention: 40 minutes of bilateral intraoral chilling
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 50 mg of oral sumatriptan
Number of subjects: 35

Group type: COMPARATOR
Intervention: Sham (tongue) chilling
Number of subjects: 35
Study: 9402268

Group type: EXPERIMENTAL
Intervention: r-hFSH
Number of subjects: 235

Group type: COMPARATOR
Intervention: u-hFSH HP
Number of subjects: 235
Study: 7963911

Group type: EXPERIMENTAL
Intervention: Heat-killed Mycobacterium leprae, BCG, or a combination of the two (vaccination)
Number of subjects: 893

Group type: COMPARATOR
Intervention: Unvaccinated (control group)
Number of subjects: 893

Group type: COMPARATOR
Intervention: Unvaccinated, lepromin-negative contacts (control subgroup)
Number of subjects: 893

Group type: EXPERIMENTAL
Intervention: Vaccination (overall effect)
Number of subjects: 893

Group type: EXPERIMENTAL
Intervention: Vaccination (specific effect on lepromatous leprosy)
Number of subjects: 893
Study: 2441535

Group type: EXPERIMENTAL
Intervention: sotalol (160‐320 mg p.o.) + mexiletine (600‐800 mg p.o.)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: sotalol (160‐320 mg p.o.) + tocainide (800‐1200 mg p.o.)
Number of subjects: 34

Group type: COMPARATOR
Intervention: sotalol/mexiletine
Number of subjects: 34

Group type: COMPARATOR
Intervention: sotalol/tocainide
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: sotalol/mexiletine and sotalol/tocainide
Number of subjects: 34
Study: 30928284

Group type: EXPERIMENTAL
Intervention: Simultaneous RRT
Number of subjects: 41

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 41
Study: 29992272

Group type: EXPERIMENTAL
Intervention: Nicotinamide riboside (NR) 1000 mg twice daily for 12 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 27822169

Group type: EXPERIMENTAL
Intervention: Dietary nitrate supplementation (8 mmol·potassium nitrate·d‐1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-caloric placebo
Number of subjects: 0
Study: 24796849

Group type: EXPERIMENTAL
Intervention: Negative affect at time j
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Smoking urge at time j
Number of subjects: 302
Study: 22206748

Group type: EXPERIMENTAL
Intervention: Pulsatile infusion of oxytocin
Number of subjects: 520

Group type: COMPARATOR
Intervention: Continuous infusion of oxytocin
Number of subjects: 520
Study: 20184764

Group type: EXPERIMENTAL
Intervention: Cascading of a multi‐professional training package to enhance midwifery and obstetric skills in the assessment, repair and postnatal management of perineal trauma.
Number of subjects: 0
Study: 18602511

Group type: EXPERIMENTAL
Intervention: 60 cc of gin (18.5 g of ethanol)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 180 cc of red wine (18.9 g of ethanol)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (120 cc of water)
Number of subjects: 45
Study: 15857851

Group type: EXPERIMENTAL
Intervention: Early eptifibatide given in the emergency room
Number of subjects: 102

Group type: COMPARATOR
Intervention: Late or no eptifibatide
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Early eptifibatide
Number of subjects: 102
Study: 12637206

Group type: EXPERIMENTAL
Intervention: Watching an 83‐minute horror film (The Texas Chainsaw Massacre, 1974)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sitting quietly in a room (control group)
Number of subjects: 32
Study: 10709856

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (2 g/day of elemental calcium)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8775164

Group type: EXPERIMENTAL
Intervention: Protocol A: Cycling at 75% Wmax until exhaustion
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Protocol B: Preload of 45 min at 70% Wmax followed by 15 min of maximal work
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Protocol C: Time trial to complete a preset amount of work as fast as possible
Number of subjects: 30
Study: 1477851

Group type: EXPERIMENTAL
Intervention: Dextromethorphan (60 or 90 mg p.o. q.i.d.)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 6716067

Group type: EXPERIMENTAL
Intervention: Maximum exercise stress test (MEST)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 3537442

Group type: EXPERIMENTAL
Intervention: Physical exercise (30 sessions over 10 weeks)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (untrained)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Trained patients (exercise group)
Number of subjects: 41
Study: 31785116

Group type: EXPERIMENTAL
Intervention: Total cefuroxime
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Unbound cefuroxime
Number of subjects: 11
Study: 30193176

Group type: EXPERIMENTAL
Intervention: Carrying a load with 10% body mass
Number of subjects: 29

Group type: COMPARATOR
Intervention: Carrying no load (CON)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Carrying a load with no added weight (empty box)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Carrying a load with 5% body mass
Number of subjects: 29
Study: 28631453

Group type: EXPERIMENTAL
Intervention: Propofol-dexmedetomidine (PD group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propofol-remifentanil (PR group)
Number of subjects: 60
Study: 26041041

Group type: EXPERIMENTAL
Intervention: Bivalent genogroup 1 genotype 1 (GI.1)/GII.4 norovirus vaccine (50 μg of VLPs of each strain)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Bivalent genogroup 1 genotype 1 (GI.1)/GII.4 norovirus vaccine
Number of subjects: 100
Study: 23942074

Group type: EXPERIMENTAL
Intervention: Paclitaxel-carboplatin±bevacizumab
Number of subjects: 759
Study: 21388734

Group type: EXPERIMENTAL
Intervention: Limited English proficient callers
Number of subjects: 971

Group type: EXPERIMENTAL
Intervention: Limited English proficient callers attempting bystander CPR
Number of subjects: 971

Group type: COMPARATOR
Intervention: English-fluent callers
Number of subjects: 971

Group type: COMPARATOR
Intervention: English-fluent callers attempting bystander CPR
Number of subjects: 971
Study: 18633677

Group type: EXPERIMENTAL
Intervention: Decreased monocyte chemoattractant protein-1 ratio
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Monocyte chemoattractant protein-1 ratio
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Carcinoembryonic antigen levels
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Serosal invasion
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Monocyte chemoattractant protein-1 expression
Number of subjects: 101
Study: 16933188

Group type: EXPERIMENTAL
Intervention: Viasys‐Jäger‐APS system
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: AKITA‐System (controlled inhalations)
Number of subjects: 30
Study: 11911356

Group type: EXPERIMENTAL
Intervention: Intragastric infusion of Lipofundin S 20% (306 kcal)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Intragastric infusion of saline
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Intraesophageal infusion of 0.2 N HCl with Lipofundin S 20%
Number of subjects: 19

Group type: COMPARATOR
Intervention: Intraesophageal infusion of 0.2 N HCl diluted in saline
Number of subjects: 19
Study: 10374374

Group type: EXPERIMENTAL
Intervention: Captopril (n = 52)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Conventional treatment (n = 49)
Number of subjects: 101
Study: 7714309

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT); Components: cognitive restructuring and assertion training; Population size: 24
Number of subjects: 33

Group type: COMPARATOR
Intervention: Information‐Focused Therapy (IFT); Components: relaxation training, nutritional and vitamin guidelines, dietary and lifestyle recommendations, aspects of child management training and assertion training; Population size: 9
Number of subjects: 33
Study: 2623126

Group type: EXPERIMENTAL
Intervention: Fast-paced music
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Slow-paced music
Number of subjects: 114

Group type: COMPARATOR
Intervention: No music
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Rock condition
Number of subjects: 114

Group type: COMPARATOR
Intervention: Heartbeat condition
Number of subjects: 114
Study: 320828

Group type: EXPERIMENTAL
Intervention: Lofepramine 70 mg t.i.d.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imipramine 50 mg t.i.d.
Number of subjects: 0
Study: 31411126

Group type: EXPERIMENTAL
Intervention: α-ketoglutaric acid (α-KG) and 5-hydroxymethylfurfural (5-HMF) supplementation
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 29410318

Group type: EXPERIMENTAL
Intervention: 1% diacerein cream
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 27089521

Group type: EXPERIMENTAL
Intervention: Lurasidone
Number of subjects: 356

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 356
Study: 25472724

Group type: EXPERIMENTAL
Intervention: Carbohydrate drinks (Nutricia pre‐Op) given the night before and the morning of surgery
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo drinks of equal volume
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Carbohydrate drinks (Nutricia pre‐Op)
Number of subjects: 30
Study: 22915447

Group type: EXPERIMENTAL
Intervention: Donepezil 5 mg
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Donepezil 10 mg
Number of subjects: 550

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 550
Study: 20335632

Group type: EXPERIMENTAL
Intervention: Multi-micronutrient supplement (daily dose containing vitamins A, B complex, C, D, E, folic acid, copper, iron, and zinc)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Multi-micronutrient supplement
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study: 18242753

Group type: EXPERIMENTAL
Intervention: Conservative treatment (pelvic muscle exercises plus advice on healthy living)
Number of subjects: 47
Study: 16170249

Group type: EXPERIMENTAL
Intervention: Body weight support treadmill training (BWSTT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional overground gait training (COGT)
Number of subjects: 20
Study: 12525522

Group type: EXPERIMENTAL
Intervention: 6 FEC 50
Number of subjects: 621

Group type: COMPARATOR
Intervention: 3 FEC 50
Number of subjects: 621

Group type: COMPARATOR
Intervention: 3 FEC 75
Number of subjects: 621
Study: 10828560

Group type: EXPERIMENTAL
Intervention: Gamma irradiation (192Ir, 15 Gy at 2 mm from the source)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 8953680

Group type: EXPERIMENTAL
Intervention: ornidazole 40 mg/kg as a single dose
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: metronidazole 15 mg/kg as one dose for 7 days
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: mebendazole 100 mg t.i.d. for 7 days
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: mebendazole 100 mg t.i.d. for 1 day
Number of subjects: 48
Study: 1801385

Group type: EXPERIMENTAL
Intervention: Tympanometry (test group)
Number of subjects: 3166

Group type: COMPARATOR
Intervention: Control group (no tympanometry)
Number of subjects: 3166
Study: 7290862

Group type: EXPERIMENTAL
Intervention: Biofeedback training with trainer present
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Biofeedback training with trainer absent
Number of subjects: 10

Group type: COMPARATOR
Intervention: Information/placebo control with trainer present
Number of subjects: 10
Study: 29703118

Group type: EXPERIMENTAL
Intervention: Total testosterone (model II)
Number of subjects: 816

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure (SBP) * total testosterone (model III)
Number of subjects: 816

Group type: COMPARATOR
Intervention: Framingham Risk Score (FRS) variables (model I)
Number of subjects: 816

Group type: COMPARATOR
Intervention: Model I
Number of subjects: 816

Group type: EXPERIMENTAL
Intervention: Model II
Number of subjects: 816

Group type: EXPERIMENTAL
Intervention: Model III
Number of subjects: 816
Study: 29389568

Group type: EXPERIMENTAL
Intervention: 3 g of pearl powder/d (n=10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 3 g of placebo/d (n=10)
Number of subjects: 20
Study: 26364892

Group type: EXPERIMENTAL
Intervention: Cognitive speed of processing training (SOPT) - 10 initial hours on-site
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Cognitive speed of processing training (SOPT) - 10 initial hours on-site plus 4 hours of boosters
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Cognitive speed of processing training (SOPT) - 10 initial hours at-home
Number of subjects: 681

Group type: COMPARATOR
Intervention: Attention-control group - 10 initial hours on-site of crossword puzzles
Number of subjects: 681
Study: 24872573

Group type: EXPERIMENTAL
Intervention: Electrical vestibular stimulation with feet together
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Electrical vestibular stimulation with increased stance width
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lateral light touch to produce anisotropy in stability
Number of subjects: 0
Study: 22735277

Group type: EXPERIMENTAL
Intervention: 200-units of Botox® (n = 7)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 300-units of Botox® (n = 5)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Saline (n = 5)
Number of subjects: 17
Study: 19917841

Group type: EXPERIMENTAL
Intervention: Cediranib 30 mg
Number of subjects: 296

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 296
Study: 18622549

Group type: EXPERIMENTAL
Intervention: MIS suite
Number of subjects: 16
Study: 15757849

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided interstitial laser photocoagulation (ILP)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 30
Study: 12443806

Group type: EXPERIMENTAL
Intervention: Sucralfate
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 10852262

Group type: EXPERIMENTAL
Intervention: SLE-specific risk adjustment index
Number of subjects: 4994

Group type: COMPARATOR
Intervention: Charlson index
Number of subjects: 4994
Study: 9735592

Group type: EXPERIMENTAL
Intervention: Extreme elbow flexion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Deviated wrist postures, forearm postures, and pinch type
Number of subjects: 20
Study: 1845438

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 0
Study: 6179337

Group type: EXPERIMENTAL
Intervention: UVB exposure 2-3 times weekly for 4 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: UVA exposure 2-3 times weekly for 4 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PUVA exposure 2-3 times weekly for 4 weeks
Number of subjects: 0
Study: 31515911

Group type: EXPERIMENTAL
Intervention: Occlusal plane angulation of 2°
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Occlusal plane cant
Number of subjects: 120
Study: 28212320

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with dairy foods
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low-fat control diet
Number of subjects: 40
Study: 26483209

Group type: EXPERIMENTAL
Intervention: Chamomile tea for 2 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Regular postpartum care only (Control)
Number of subjects: 80
Study: 24604768

Group type: EXPERIMENTAL
Intervention: Songs with pro-integration lyrics
Number of subjects: 0
Study: 22147248

Group type: EXPERIMENTAL
Intervention: HBV vaccination in IBD patients
Number of subjects: 102

Group type: COMPARATOR
Intervention: HBV vaccination in healthy controls
Number of subjects: 102
Study: 20152225

Group type: EXPERIMENTAL
Intervention: Biventricular (BiV) pacing with Closed Loop Stimulation (CLS)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Biventricular (BiV) pacing with accelerometer
Number of subjects: 108

Group type: COMPARATOR
Intervention: Right ventricular (RV) pacing
Number of subjects: 108
Study: 17432680

Group type: EXPERIMENTAL
Intervention: Total glucosides of paeony (TGP) combined with sulfasalazine (SSZ)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Methotrexate (MTX) combined with sulfasalazine (SSZ)
Number of subjects: 67
Study: 16123958

Group type: EXPERIMENTAL
Intervention: Delayed low-dose tacrolimus (target trough level 4-8 ng/mL, starting day 4-6) with daclizumab and mycophenolate mofetil
Number of subjects: 148

Group type: COMPARATOR
Intervention: Standard-dose tacrolimus with mycophenolate mofetil
Number of subjects: 148
Study: 12069736

Group type: EXPERIMENTAL
Intervention: Buserelin 150 microg nasal spray three times daily (Group B)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Nafarelin nasal spray 400 microg twice daily (Group N)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Leuprorelin depot 3.75 mg once by intramuscular or subcutaneous injection (Group L)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Nafarelin group
Number of subjects: 157
Study: 10195475

Group type: EXPERIMENTAL
Intervention: Buffered lidocaine (BL)
Number of subjects: 271

Group type: COMPARATOR
Intervention: Plain lidocaine (PL)
Number of subjects: 271
Study: 8504631

Group type: EXPERIMENTAL
Intervention: Formula with 6.5:93.5 non-protein nitrogen/protein nitrogen ratio
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Formula with 11.4:88.6 non-protein nitrogen/protein nitrogen ratio
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Formula with 17.5:82.5 non-protein nitrogen/protein nitrogen ratio
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Formula with higher proportion of non-protein nitrogen
Number of subjects: 30

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 30
Study: 3304348

Group type: EXPERIMENTAL
Intervention: Cefazolin sodium, 1 g intravenously, one hour prior to surgery and a similar dose eight hours later
Number of subjects: 101

Group type: COMPARATOR
Intervention: No antibiotics
Number of subjects: 101
Study: 29059293

Group type: EXPERIMENTAL
Intervention: Bonded retainers (BRs)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Vacuum-formed retainers (VFRs)
Number of subjects: 60
Study: 27765759

Group type: EXPERIMENTAL
Intervention: Farglitazar
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Balaglitazone
Number of subjects: 0